Middle meningeal artery embolization in chronic subdural hematoma: a paradigm shift?

• by Yan Li, Johannes Haubold, Natalie van Landeghem, Cornelius Deuschl, Ramazan Jabbarli, Philipp Dammann, Ulrich Sure, Isabel Wanke, Luisa Strack, Michael Forsting

• June 10, 2026

Salvage microsurgery for vestibular schwannoma after failed stereotactic radiosurgery: a multi-institutional retrospective study

• by Filippo Friso, Noa Ben Dor, Alfredo Conti, Alfredo Decio Fabbri, Federico Calvaruso, Virginia Dallari, Francesca De Cecco, Franco Federico Bochicchio, Emanuele La Corte, Tomasz Wojciechowski, Kazimierz Niemczyk, Adrian Drożdż, Grzegorz Turek, Lukas Anschuetz, Davide Soloperto, Giacomo Pavesi, Barbara Masotto, Daniele Marchioni, Carmelo Sturiale, Paolo Ferroli, Francesco DiMeco, Livio Presutti, Giulia Molinari

• May 20, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

• by Kathryn Wighton

• June 15, 2026

• 3 min

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

• by Kathryn Wighton

• May 14, 2026

• 6 min